Atlas Trials

Type 2 Diabetes Patients With Renal Impairment

Clinical trial NCT04221399 · UNKNOWN

Trial details

NCT number
NCT04221399
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2020-01-01
Primary completion
2020-08-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.